Perrigo analgesic, cough/cold volume growth boosts third-quarter sales 6%.
This article was originally published in The Tan Sheet
Executive Summary
PERRIGO ANALGESIC SALES GROW 6% IN THE THIRD QUARTER ended March 31, the company said May 9, adding that the increase is the highest quarterly gain the analgesic group has posted in two years. Perrigo's largest product category, cough/cold products, recorded a 14% sales increase in the third quarter, while the overall cough/cold market declined 7%, Perrigo said.